When to See a Doctor: The Beginning of Stevens Johnson Syndrome

September 2009

First described in 1922, Stevens Johnson Syndrome is named for its ‘discoverers’, M. Stevens, and F. C. Johnson, who published A new eruptive fever associated with stomatitis and ophthalmia; report of two cases in children. American Journal of Diseases of Children, Chicago, 1922, 24: 526-533.

SJS is thought to arise due to a disorder of the immune system, described as a reaction to medication or infection. It tends to occur in winter and early spring, and affects twice as many men as women.

“Missed diagnosis is common.” – Emedicine.

Most authors and experts consider Stevens Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) to be different levels of severity for the same disease. Because of this, most Medical sources use the term “SJS/TEN”.

How Does it Start?
SJS typically begins with an upper respiratory tract infection, like a cold or flu.

It then behaves like flu for up to two weeks, including fever, sore throat, chills, and headache; in some people there is also vomiting and diarrhea.

Then suddenly, there are blisters in the mucous membranes – especially nose, mouth and eyes. These clusters of blisters last from two to four weeks and are not itchy.

Fever is reported in 85% of cases.

When Should I Get Medical Help?
These are some early warning signs of Stevens Johnson Syndrome:

• Skin pain over large areas of the body
• Blisters, especially on the mucous membranes
• Hives
• Swelling of the tongue and face
• A red or purple rash that spreads
• Shedding skin

Shedding Skin – How Stevens Johnson Syndrome is Classified
The number of people who die from Stevens Johnson Syndrome is related to the amount of skin lost in the sloughing process in the later stages of the disorder. The simplest of the classifications have three stages:

Stevens Johnson Syndrome – less than ten percent of the body surface skin is lost. Between 1% and 5% of patients die.
Stevens Johnson / toxic epidermal necrolysis (SJS/TEN) - 10% to 30% of the skin is lost.
Toxic epidermal necrolysis – More than thirty percent of the body surface area is detached. Mortality is between 25% and 35%.

If you have developed the Stevens Johnson Syndrome (SJS), and have taken the epileptic drug Dilantin®, please speak with us now. You may be entitled to compensation! Contact Eric W. Gruenwald, Attorney / Lawyer, for more information. You can reach him at 866-529-0001, Extension 245.

Reglan® Can Cause Tardive Dyskensia

September 2009

Every year millions of Americans suffer from stomach disorders like diabetic gastroparesis and gastroesophageal reflux disorder (GERD) and get prescribed Reglan® routinely. In a bid for relief, most patients follow their medical practitioner’s prescription blindly, not knowing what may lie in store ahead. Reglan® or metoclopramide can have terrible side effects like Tardive Dyskinesia which can be a very debilitating disease.

Reglan® is available in the form of Reglan® Tablets, Reglan® Oral Disintegrating Tablets, Metoclopramide® Oral Solution and Reglan® Injection.

Reglan® Side Effects
Tardive Dyskinesia is not a dismissible side effect by any count and can alter the health and quality of life of a person as this affects the neurons, nerve cells. The symptoms of this are like drug induced movement disorders and the most alarming thing is that most are rarely reversible.

Tardive Dyskinesia symptoms are uncontrollable movements of the tongue, lips or jaw, facial grimacing, tongue protrusion, lips puckering, involuntary movements of arms, legs, fingers and toes and swaying movements of the trunk or hip. These movements are usually repetitive and jerky.

Tardive Dyskinesia is almost incurable and most victims have to put up with the symptoms for the rest of their lives. Usually, the first symptoms are not noticed by the patients themselves but by family or friends. These may manifest long after Reglan® usage has been stopped.

FDA & Reglan®
On February 26th, 2009, The U.S. FDA announced that manufacturers of metoclopramide must add a boxed warning to their drug labels about the risk of its long-term or high-dose use.

The Law & Reglan®
If you or your loved ones have been injured through the use of Reglan®, waste no more time. You are potentially entitled to compensation. Contact Eric W. Gruenwald, Attorney/Lawyer for more information at 866-529-0001 Extension 245.

The FDA Dilantin® Alert: What does it Mean for You?

September 2009

Last year the Federal Food and Drug Administration came out with an alert for Dilantin® (phenytoin), one of the oldest and still most commonly prescribed anti-epileptic, anti-convulsion drugs.

There are a number of other drugs out there for epilepsy and seizure disorders (14 counted on WebMD alone), but the Stanford Hospital and Clinics website says that Dilantin® is the most popular for treatment of partial and secondarily generalized seizures in the United States.

A lot of epileptics and people with other seizure disorders take Dilantin®.

The side-effect being studied in relation to Dilantin® in this alert is an allergic skin reaction that goes by the name of Stevens Johnson Syndrome, or SJS. (TEN, Toxic Epidermal Necrolysis, is also considered to be part of SJS. The really bad part of SJS).

Here’s the Alert, verbatim from www.fda.gov:
FDA ALERT [11/24/08]: FDA is investigating new preliminary data regarding a potential increased risk of serious skin reactions including Stevens Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) from phenytoin therapy in Asian patients positive for a particular human leukocyte antigen (HLA) allele, HLA-B*1502. This allele occurs almost exclusively in patients with ancestry across broad areas of Asia, including Han Chinese, Filipinos, Malaysians, South Asian Indians, and Thais.

OK, in plain english, what does this mean?

An allele is half of a genetic pair. The HLA-B*1502 allele is only present (with rare exception) in people of Asian ancestry. At this time it looks like there may be a link between the HLA-B*1502 allele and Stevens Johnson syndrome (SJS) and also Toxic Epidermal Necrolysis (TEN).

The FDA alert does not mean that SJS and TEN don’t occur in other populations; it means that if you are of Asian ancestry, and you do have this genetic marker, there appears to be heightened risk for a rare, life-threatening allergic disorder.

Maybe yes, maybe no…

The FDA Alert continues: The possible risk of SJS from phenytoin and fosphenytoin in patients with HLA-B*1502 is still being studied; however, there is not yet enough information to recommend testing for HLA-B *1502 in Asian patients for whom phenytoin treatment is contemplated.

The FDA point of view seems to be that’s there’s room to worry but nothing conclusive. The SJS/Dilantin® link is important enough to devote money to the study of the HLA-B*1502 allele, but not important enough at this time to mandate routine genetic tests for those taking Dilantin® who are of Asian descent.

The bottom line: if you take Dilantin®, there’s the risk of the Stevens Johnson Syndrome (SJS) side effect, whether you are of Asian descent or not. If you need representation, you’ve come to the right website!

The Mulligan Law Firm is a national law firm located in Dallas, Texas who provides information and resources for injured individuals and their families in all 50 states. The firm has successfully resolved over $600,000,000 in claims for its clients since 1995, and they are currently investigating injury claims involving Dilantin® and Stevens Johnson Syndrome (SJS).

Levaquin Tendon Injuries Now Being Evaluated By Texas, California, & Florida Attorneys At The Mulligan Law Firm

July 2009

Levaquin:
 
Levaquin is a brand-name of Levofloxacin, a synthetic chemotherapeutic agent that belongs to a class of broad-spectrum antibiotics called fluroquinolones. Levaquin is a prescription-based drug that can be used by adults in the treatment of pneumonia, skin-infections, sinusitis, bronchitis, kidney infections, bladder infections, prostate infections, and inhaled-anthrax.

Levaquin Side-Effects:
 
A number of serious side-effects have been associated with the use of Levaquin. Those side effects include Achilles tendon ruptures, ruptures to the shoulder, hand, biceps and thumb. In addition, serious tendon damage has also been reported in patients prescribed Levaquin.
 
Levaquin and the FDA:
 
In October 2008, the Food and Drug Administration issued an alert that stated: “Fluoroquinolones, including Levaquin, are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart and lung transplants.”
 
The FDA added: “Tendon rupture can occur during or after completion of therapy; cases occurring up to several months after completion of therapy have been reported. Levaquin should be discontinued if the patient experiences pain, swelling, inflammation or rupture of a tendon. Patients should be advised to rest at the first sign of tendinitis or tendon rupture, and to contact their health-care provider regarding changing to a non-quinolone antimicrobial drug.”
 
Levaquin Lawsuits:
 
If you or a loved one has been seriously injured after taking Levaquin, contact us right now. We have experienced lawyers standing by right now to help you. You may be entitled to compensation for your injuries. We take all cases on a contingency-fee basis, which means you do not pay for our services unless you receive an award or compensation. Do not Delay. Your rights and compensation may be lost forever if you wait.  Please contact Eric W. Gruenwald, Attorney / Lawyer for more information at 866-529-0001  Extension 245

Accutane® Potential Claims Now Being Investigated Nationwide By California, Texas, & Florida Attorneys At The Mulligan Law Firm

July 2009

Accutane®:
 
Acctutane® (a marketed name of Isotretinoin) is used in the treatment of severe nodular acne. It is generally used in patients who fail to significantly respond to other forms of acne treatments, such as antibiotics. Accutane works by reducing the amount of oil released by oil-glands in the skin, and helps the skin to renew itself.
 
Accutane Side-Effects:
 
Individuals taking Isotretinoin may experience side effects including severe headaches, blurred vision, dizziness, nausea, vomiting, seizures, stroke, diarrhea, and muscle weakness. Additionally, serious mental health problems, such as depression and suicide, have been reported with Isotretinoin use.
 
Accutane and the FDA:
 
According to the Food and Drug Administration: “Isotretinoin is a potentially dangerous prescription medicine that should only be taken under the close supervision of your health-care professional and pharmacist. If you are pregnant or may get pregnant, Isotretinoin can cause birth defects, miscarriage, premature births, and death in babies. Buying this product over the Internet bypasses important procedures to ensure that patients can take this drug safely. When these procedures are ignored, Isotretinoin can cause serious and harmful side effects.”
 
Accutane Lawsuits:
 
If you or a loved one has been seriously injured after taking Accutane, contact us right now. We have experienced lawyers standing by right now to help you. You may be entitled to compensation for your injuries. We take all cases on a contingency-fee basis, which means you do not pay for our services unless you receive an award or compensation. Do not Delay. Your rights and compensation may be lost forever if you wait.  Please contact Eric Gruenwald, Attorney / Lawyer at 1-866-529-0001, Extension 245.    

 

The Texas, California, & Florida Attorneys / Lawyers Of The Mulligan Law Firm Are Now Evaluating Nationwide Accutane® Injury Cases

June 2009

 The Mulligan Law Firm is evaluating injuries related to the use of the prescription drug Accutane®.  Accutane ® is a registered trademark of Hoffman – La Roche, Inc.

If you or a loved one knows of someone potentially injured by Accutane®, please contact The Mulligan Law Firm immediately. The Firm is very interested in speaking with you as soon as possible, and evaluating and investigating your potential claim at no cost.

Accutane® is an acne treatment drug. 

Accutane® was pulled from the US market in June, 2009.  It is allegedly associated with several serious side effects including Inflammatory Bowel Disease (IBD), Colitis, and Crohn’s Disease.  If you or a loved one suffered any serious side effects after taking Accutane®, the lawyers at The Mulligan Law Firm would like to speak with you concerning your potential case.  Such investigatory consultations are confidential and free.  

Statutes of limitations require potential plaintiffs to act within established time-frames. Any failure or delay in contacting an attorney may result in a potential claimant losing his or her rights.

Do not delay: contact The Mulligan Law Firm today if you have questions and concerns about alleged injuries from the use of Accutane®.

The Mulligan Law Firm:

Since its formation in 1995, The Mulligan Law Firm has successfully represented thousands of individuals in a wide variety of practice areas in federal and state courts throughout the United States, and has achieved recoveries for its clients exceeding well over $600,000,000.00  (Six Hundred Million) U.S. dollars. The firm obtained an AV rating with Martindale-Hubbell which indicates very high to preeminent legal ability and very high ethical standards as established by confidential opinions from members of the Bar.

For more information on potential alleged Accutane® injuries and The Mulligan Law Firm, please see our website.

The Mulligan Law Firm’s Texas, California, and Florida Lawyers / Attorneys are evaluating nationwide claims involving Accutane® injuries. 

The Mulligan Law Firm represents clients throughout the United States in conjunction with local counsel licensed in other jurisdictions.

Contact:

PATRICK J. MULLIGAN, Attorney, Lawyer*
ERIC W. GRUENWALD, Attorney, Lawyer**
The Mulligan Law Firm
866-529-0001, EXT. 245
214-219-9779, EXT. 245
Email:  help@mulliganlaw.com
For details about our attorneys and areas of practice, see:
http://www.mulliganlaw.com

*   Licensed in Texas & Georgia.
** Licensed in California only.

Asbestos Producing Companies That May Have Set Up Trusts To Provide Settlement Benefits For Those Injured By Asbestos, Including Lung Cancer, Mesothelioma, Etc.

June 2009

If you or a loved one worked around or with products created by any of the following companies, and later developed lung cancer or mesothelioma, we would like to speak with you regarding your legal rights.  The following companies may have entered bankruptcy (often as a result of the number of asbestos-injury claims brought against them) and set up trust accounts to provide settlements / benefits for those injured by Asbestos Products.  In some cases, the year the company declared bankruptcy is listed after the name of the company: 

ABB Lummus Global 2006
A-Best Products 2002
ACandS, Inc. 2002
Amatex Corp. 1982
American Shipbuilding Co. 1993
Ancor Holdings/National Gypsum 1990
API Inc. 2005
A.P. Green Industries, Inc.
A.P. Green International, Inc.
A.P. Green Refractories
A.P. Green Services, Inc.
API Inc. 2005
Armstrong World Industries 2000
Artra Group, Inc. 2002
Asarco, Inc. 2005
Asbestospray
Babcock & Wilcox Co. 2000
Brauer Supply Co. 2005
Brunswick Fabricators 1998
Burns & Roe 2001
Carey Canada, Inc. 1990
Cassiar Mines 1992
Celotex Corp. 1990
C.E. Thurston 2003
Christy Refractories Co. 2008
Combustion Engineering 2003
Congoleum Corp. 2003
Dana Corporation 2006
Delaware Insulations Distributors 1989
Dresser Industries/Halliburton 2003
Eagle Pitcher Industries 1991
Eastco Industrial Safety Corp.
EJ Bartells Co. 2001
Federal Mogul Corp. 2001
Fibreboard Corporation
Flintkote Co. 2004
Forty-Eight Insulations 1985
Fuller-Austin Insulation Co. 1998
Gasket Holdings Inc.
Gatke Corp. 1987
G-I Holdings 2001
GlT 2002
Harbison-Walker Refractories Co. / A.P. Green Ind. / North American 2002
Harnischfeger Corp. 1999
Hercules Chemical Co. 2008
Hillsborough Holdings 1989
H.K. Porter Co. 1991
Insul Co. 2001
Johns-Manville Corp. 1982
JP Stevens 2004
JT Thorpe 2002
Kaiser Aluminum Corp. 2002
Keene Corp. 1993
Kentile Floors Inc. 1992
Lake Asbestos of Quebec 2005
Lloyd E. Mitchell Co. 2006
McLean Industries 1986
M.H. Detrick 1998
Mid-Valley /Halliburton 2003
The Muralo Co. 2003
Murphy Marine Services 2001
National Gypsum (Asbestos Claims Management Corp.)
North American Asbestos
North American Refractories Co. (NARCO) 2002
Nicolet, Inc. 1987
Ogelbay Norton (ONCO) 2004
Owens Corning/Fibreboard 2000
Pacific Insulation Co. 2007
Philadelphia Asbestos Corp. 1986
Pittsburgh Corning 2000
Plibrico Co. 2002
Porter-Hayden Co. 2002
Prudential Lines, Inc. 1986
Quigley Co. 2004
Raymark Corp./Raytech Corp. 1989
Refractories Co.
Rock Wool Manufacturing 1996
Rutland Fire Clay Co. 1999
Schutte & Koerting, Inc.
Southern Textile Corp.
Solutia, Inc.
Spraycraft
Shook & Fletcher Insulation Co. 2002
Skinner Engine Co. 2001
Special Electric Co. 2004
Special Metals Corp. 2002
Standard Insulations, Inc. 1986
Swan Transportation Co. 2001
T&N, Ltd. (part of Federal–Mogul Bankruptcy)
T H Agriculture & Nutrition 2008
Thorpe Insulation Co. 2007
Todd Shipyards 1987
Unarco Industries, Inc. 1982
United States Gypsum Company
United States Lines 1986
United States Mineral Products 2001
UNR Industries, Inc. 1982
USG Corp. 2001
Utex Industries 2004
Wallace & Gale 1984
Washington Group International
Waterman Steamship Corp. 1983
Western Macarthur 2002
W.R. Grace Co. 2001

The Mulligan Law Firm is Evaluating Raptiva® (Efalizumab) Alleged Injury Cases

June 2009

The Mulligan Law Firm is Evaluating Raptiva® (Efalizumab) Alleged Injury Cases

The Mulligan Law Firm announces that it is evaluating and investigating cases where the usage of the drug Raptiva® has allegedly led to a rare brain infection known as Progressive Multifocal Leukoencephalopathy (PML), a very serious and almost always fatal viral brain infection.    

The Mulligan Law Firm (http://www.mulliganlaw.com) is evaluating alleged injuries related to the use of the drug Raptiva®.

If you or a loved one knows of someone potentially injured by Raptiva®, you should contact The Mulligan Law Firm immediately. The firm is very interested in speaking with you, and evaluating and investigating your potential case at no cost to you.

Raptiva is a psoriasis treatment drug.  Various serious side effects have been reported. 

Raptiva was pulled from the US market in April, 2009.  It is associated with Progressive Multifocal Leukoencephalopathy (PML).  If you or a loved one suffered any serious side effects after taking Raptiva, the attorneys / lawyers at The Mulligan Law Firm would like to speak with you concerning your potential case.  Such investigatory consultations are confidential and free of charge.  

Statutes of limitations require potential plaintiffs to act within certain established time-frames. Any failure or delay in contacting an attorney may result in a potential claimant losing his or her rights.

Do not delay: contact The Mulligan Law Firm today if you have questions and concerns about alleged injuries from the use of Raptiva®.

About The Mulligan Law Firm:

The Mulligan Law Firm was formed in 1995. The firm has successfully represented thousands of individuals in a wide variety of practice areas in federal and state courts throughout the United States, and has achieved recoveries for its clients exceeding well over $600,000,000.00  (Six Hundred Million) U.S. dollars. The firm obtained an AV rating with Martindale-Hubbell which indicates very high to preeminent legal ability and very high ethical standards as established by confidential opinions from members of the Bar.

For more information on alleged Raptiva® injuries and The Mulligan Law Firm, see the website: http://www.mulliganlaw.com

The Mulligan Law Firm’s Texas, California, and Florida Lawyers / Attorneys are evaluating nationwide claims. 

The Mulligan Law Firm represents clients throughout the United States in conjunction with local counsel licensed in other jurisdictions.

Contact:

Patrick J. Mulligan, Lawyer / Attorney*
Eric Gruenwald, Lawyer / Attorney**
The Mulligan Law Firm
866-529-0001, EXT. 245
214-219-9779, EXT. 245
Email:  help@mulliganlaw.com
For details about our attorneys and areas of practice, see:
http://www.mulliganlaw.com

*   Licensed in Texas & Georgia.
** Licensed in California only.

The Mulligan Law Firm is Evaluating FLEET® PHOSPHO-SODA® Alleged Injury Cases

June 2009

The Mulligan Law Firm is Evaluating FLEET® PHOSPHO-SODA® Alleged Injury Cases

The Mulligan Law Firm announces that it is evaluating and investigating cases where the usage of FLEET® PHOSPHO-SODA® has allegedly led to acute kidney injuries.    

The Mulligan Law Firm (http://www.mulliganlaw.com) has started evaluating alleged acute kidney injuries related to the use of FLEET® PHOSPHO-SODA®.
On December 11, 2008, the Food & Drug Administration (FDA) stated that it would be adding a Boxed Warning to the prescription Oral Sodium Phosphate (OSP) products Visicol® and OsmoPrep®, to advise people of the potential risk of acute phosphate nephropathy (a type of acute kidney injury).

Patients routinely take OSP products to cleanse the bowel before a colonoscopy (colon examination) and other medical procedures.

The FDA stated it was equally concerned about the possible risks associated with the use of certain OSP products that can be purchased over-the-counter (OTC), including Fleet® Phospho-soda®, when used at higher doses for bowel cleansing. 

The available data did not demonstrate a risk of acute kidney injury when Fleet® Phospho-soda® was used at the lower doses for laxative use. 

However, the FDA added that: … “when used for bowel cleansing, these products have the same risks as prescription OSP products. FDA plans to amend the labeling conditions for OTC OSP products to address this concern with bowel cleansing use. In light of the continued receipt of reports of acute phosphate nephropathy, FDA is recommending that consumers not use over-the-counter OSPs for bowel cleansing.”

On the same day that the FDA released its statement, C.B. Fleet Company – the makers of Fleet® Phospho-Soda® – immediately announced a voluntary recall of the product.

If you or a loved one knows of someone potentially injured by Fleet® Phospho-soda®, you should contact The Mulligan Law Firm immediately. The firm is very interested in speaking with you, and evaluating and investigating your potential case at no cost to you.

The attorneys of The Mulligan Law Firm emphasize that in personal injury cases it is vital that steps are taken to preserve all available evidence, and to allow physicians and/or other expert witnesses to thoroughly evaluate any and all potential injuries.

Moreover, statutes of limitations require potential plaintiffs to act within certain established time-frames. Any failure or delay in contacting an attorney may result in a potential claimant losing his or her rights.

Do not delay: contact The Mulligan Law Firm today if you have questions and concerns about alleged injured from the use of Fleet® Phospho-soda®

About The Mulligan Law Firm:

The Mulligan Law Firm was formed in 1995. The firm has successfully represented thousands of individuals in a wide variety of practice areas in federal and state courts throughout the United States, and has achieved recoveries for its clients exceeding well over $600 million U.S. dollars. The firm obtained an AV rating with Martindale-Hubbell which indicates very high to preeminent legal ability and very high ethical standards as established by confidential opinions from members of the Bar.

For more information on birth defects and SSRI use and The Mulligan Law Firm, see the website: http://www.mulliganlaw.com

The Mulligan Law Firm’s Texas, California, and Florida Lawyers / Attorneys are evaluating nationwide claims. 

The Mulligan Law Firm represents clients throughout the United States in conjunction with local counsel licensed in other jurisdictions.

Contact:

Patrick J. Mulligan, Lawyer / Attorney*
Eric Gruenwald, Lawyer / Attorney**
The Mulligan Law Firm
866-529-0001, EXT. 245
214-219-9779, EXT. 245
Email:  help@mulliganlaw.com
For details about our attorneys and areas of practice, see:
http://www.mulliganlaw.com

*   Licensed in Texas & Georgia.
** Licensed in California only.

The Mulligan Law Firm Is Evaluating Claims Of Birth Defects Potentially Related To SSRI Antidepressant Use During Pregnancy

June 2009

The Mulligan Law Firm is Evaluating SSRI (Prozac®, Zoloft®, Lexapro®, Celexa®, and Paxil®) Birth Defect Injury Cases

The Mulligan Law Firm announces that it is evaluating and investigating cases where the usage of SSRI antidepressants such as Prozac®, Zoloft®, Lexapro®, Celexa®, and Paxil® has allegedly led to serious birth defects.  

Dallas, TX — The Mulligan Law Firm (http://www.mulliganlaw.com) has started evaluating possible birth defect injury claims involving the use if SSRI antidepressants such as Prozac®, Zoloft®, Lexapro®, Celexa®, and Paxil®.

Evidence shows that SSRI antidepressant use during pregnancy is allegedly linked to birth defects such as:

• heart defects
• anencephaly (a brain defect at birth)
• omphacele  (a birth defect in which the infant’s intestine or other
abdominal organs stick out of the belly button)
• PPHN  (Babies with PPHN have high-pressure in the blood vessels of their lungs; and, therefore, are unable to get sufficient oxygen into their bloodstream.)
• other birth defects   

If you or a loved one knows of a baby born with birth defects after the mother took  antidepressants you should contact The Mulligan Law Firm immediately. The firm is very interested in speaking with you, and evaluating and investigating your potential case.

The Mulligan Law Firm is now offering a free evaluation and investigation of potential claims related to mothers and infants whom may have suffered from the tragedy of birth defects following the use of SSRI antidepressants such as Prozac®, Zoloft®, Lexapro®, Celexa®, and Paxil® during pregnancy. 

The attorneys of The Mulligan Law Firm emphasize that in personal injury cases it is vital that steps are taken to preserve all available evidence, and to allow physicians and/or other expert witnesses to thoroughly evaluate any and all potential injuries.

Moreover, statutes of limitations require potential plaintiffs to act within certain established time-frames. Any failure or delay in contacting an attorney may result in a potential claimant losing his or her rights.

Do not delay: contact The Mulligan Law Firm today if you have questions and concerns about birth defects potentially related to the use of SSRI antidepressants such as Prozac®, Zoloft®, Lexapro®, Celexa®,  and Paxil®.

About The Mulligan Law Firm:

The Mulligan Law Firm was formed in 1995. The firm has successfully represented thousands of individuals in a wide variety of practice areas in federal and state courts throughout the United States, and has achieved recoveries for its clients exceeding well over $600 million U.S. dollars. The firm obtained an AV rating with Martindale-Hubbell which indicates very high to preeminent legal ability and very high ethical standards as established by confidential opinions from members of the Bar.

The Mulligan Law Firm would like to hear from you to discuss your potential claim.

For more information on birth defects and SSRI use and The Mulligan Law Firm, see the website: http://www.mulliganlaw.com

The Mulligan Law Firm’s Texas, California, and Florida Lawyers / Attorneys are evauating nationwide claims. 

The Mulligan Law Firm represents clients throughout the United States in conjunction with local counsel licensed in other jurisdictions.

Contact:

Patrick J. Mulligan, Lawyer / Attorney*
Eric Gruenwald, Lawyer / Attorney**
The Mulligan Law Firm
214-219-9779, EXT. 245
866-529-0001, EXT. 245
Email:  help@mulliganlaw.com

For details about our attorneys and areas of practice, see:
http://www.mulliganlaw.com

*   Licensed in Texas & Georgia.
** Licensed in California only.